Personalized Medicine Where Traditional Chinese Medicine and Western Medicine Can Meet
|
|
- Jordan Ernest Short
- 6 years ago
- Views:
Transcription
1 Personalized Medicine Where Traditional Chinese Medicine and Western Medicine Can Meet Dr. Jean Paul Collet MD, PhD, Prof. - University of British Columbia - Child and Family Research Institute - BC Children s Hospital jpcollet@gmail.com WFCMS Sravan Jaggumantri, PhD student Arianne Toleno 4th International Conference on the Modernization of Traditional Chinese Medicine Chengdu, China Sept 26-27, 2013
2 Outline 1. Evidence-based Medicine approach 2. Traditional Chinese Medicine approach 3. Development of Patient Centred Medicine approach in Western Medicine 4. Could Patient Centred Medicine be used to evaluate TCM?
3 Basic Research Knowledge WFCMS Western Approach: A Snapshot Clinical Trials Phase 1-3 Efficacy Knowledge Pragmatic trials & Comparative Effectiveness Cohort Case Control Effectiveness Knowledge HTA Good Practice Evidence Based Knowledge Genetic? Clinical Assessment Personalized Outcomes Utility Individualized treatment Personalized Treatment Useful Treatment! Patient Oriented Research Useful Practice: patient s view
4 Western Approach: Evidence-Based Western Medicine Evaluation standard: based on Randomized Trials - On average, the treatment gives better results than the placebo - For public health and economic reasons, we recommend the use of treatment - Assuming average effect and good compliance economic models can demonstrate the positive effects of using drugs
5 Western Approach: Evidence-Based WFCMS Patients treated by beta-blockers death after myocardial infarction have a 20% risk reduction of death (fictitious example to illustrate the point) The risk of death in 1230 subjects treated by beta-blockers was 12%, while the risk in the 1240 subjects treated by placebo the risk was 15% (15% - 12%) / 15% = 20% However, the true risk reduction is 15% - 12%= 3%
6 Western Approach: Evidence-Based Western Approach of Evidence: - Population-based evaluation - For public health decisions Perspective: - Public Health Policy Maker - Pharmaceutical Industry WFCMS Evidence-Based Medicine Clinical Practice Guidelines Practice of Medicine Based on what has been observed as average effect at population level NO SURPRISE: PATIENTS ARE NOT HAPPY!
7 Traditional Chinese Medicine Therapeutic Diagram Yin/Yang balance Qi/Blood pattern Organ identification External factors identification TCM Diagnosis TCM Syndrome Differentiation WFCMS Inspection Interrogation Palpation Listening and Smelling TCM Intervention Multifactorial Herbal treatment Acupuncture/pressure Energy based (Qigong/Tai chi) According to Chinese Syndromes
8 Yin-Yang Balance Yin-Yang balance Yin-Yang imbalance Health Disease Balance Yin deficiency WFCMS TCM Therapeutic Diagram Yin Yang Yang deficiency Yin excess Yang excess
9 From Symptoms to Syndromes and Treatment food and taste stools and urine body energy sleep tongue pulse complexion Heart-and-Spleen-Qi Deficiency Heart-Blood Deficiency Yin Deficiency Yang Deficiency Four-Gentlemen Decoction - basic herb formula Four-Gentlemen Decoction modified by herbs: A,B,D,F Four-Gentlemen Decoction modified by herbs : B,D,F,G,H Four-Gentlemen Decoction modified by herbs : A,C,E Prescription is tailored to patients' syndrome, not to specific clinical symptoms TCM is Patient Centred with main goal to improve clinical outcomes and patients wellbeing
10 Clinical Status TCM Diagnosis Syndrome 1 Prescription 1 Clinical Status 2 Clinical Status 3 WFCMS TCM Action: A Cascade of Effects to Rebuild Energy, Balance and Circulation TCM Diagnosis TCM Diagnosis Syndrome 2 Syndrome 3 Prescription 2 Prescription 3 «Tailored and adaptative» Repair
11 SUMMARY: Western vs TCM Approach Western Approach of Evidence: - Population-based evaluation - For public health decisions Perspective: - Public Health Policy Maker - Pharmaceutical Industry TCM Approach of Evidence: - Individual-based evaluation - For individual decisions Perspective: - Individual subject - Physician ASSESSING IMPACT Individual Level Public Health Level TCM +/- Western Med +/-
12 Development of Patient Centred Medicine WHY? WHAT?
13 Goal setting and attainment in Alzheimer s disease patients treated with donepezil jnnp.bmj.com on May 6, month phase 4 trial, 108 patients with mild to moderate disease Physicians and Caregivers set goals particularly in domains of functionality : autonomy, leisure, social interaction Patient/career global global goal scores correlated moderately with the physician s CIBIC + at week 12 and 52 (r=.52 and.56, respectively); and not with ADA-cog. Disease Assessment Scale-Cognitive (ADAS-cog), and the Clinician s Interview-Based Impression of Change-Plus (CIBICplus)
14 EXAMPLE FABRY DISEASE WFCMS Rare X-linked recessive disease Deficiency of enzyme alpha galactosidase A due to mutation Accumulation of a glycolipid within the blood vessels, other tissues, and organs: Sphingolipidosis Pain: Full body or localized, GI Renal involvement: Proteinuria, kidney insufficiency Cardio-vascular manifestations: Hypertension, cardiomyopathy, aneurysm, Dermatological manifestations: Angiokeratomas, anhidrosis, Raynaud s dis. Ocular manifestations: Keratopathy, macular edema, optic atrophy, cataract Neurological manifestations: Neuropathy Other manifestations: Fatigue, stroke, vertigo, tinnitus, diarrhea, vomiti In practice drug efficacy was assessed on the change of sphingolipid accumulation in the skin biopsy
15 Patient insights in trial Parents are fighting to keep a drug to treat autism and fragile X syndrome that failed clinical trials on the market because it has helped their children. design
16 Methodological Development Outcome has to be personal, specific and important - Which ones? - How to find? Measurement - Measuring outcomes? - Measuring changes? - How to assess utility of a change? - Validity reliability Design - N-of-1 type of design Validity external and internal Impact Patient Centred Medicine
17 Goal Attainment Scaling Step 1: Establishment of personal important outcomes in each individual. Mutual agreement is a key component of PCM, guided by specific tools adapted from the GAS approach. Treatment effectiveness will be assessed by changes in the PSOI. Step 2: Determining the expected change over the treatment course. This process forces a precise definition of the PSOI and the criteria to assess the changes; it is often a source of insightful discussions with the family. The entire process is facilitated by the communication tools. Step 3: Scaling the observed change. The change in PSOI is assessed at the end of the treatment course. The scaling process follows a very precise rule that transforms the change into a score of success (between -2 to +2) Step 4: Determining utility and making decision by integrating information from both the traditional clinical endpoints and PSOI. A utility analysis of all the outcomes is conducted with the use of a Bayesian methodology by updating the decision on treatment effectiveness as additional evidence is acquired using the model.
18 Goal Attainment Scaling
19 Phase 1 Literature Review Conceptualizing the structural & functional framework of the PCM model Development of an adaptive GAS approach to establish PSOI Draft Internal protocols & procedures Knowledge trasfer Phase 2 Test feasbility of the PCM model Knowledge transfer Phase 3 Evaluate the PCM model on a large scale Plan for an RCT of PCM against traditional medical model Knowledge transfer Phase 4 Larger/Broader Knowledge Transfer
20 IS PATIENT CENTERED APPROACH SCIENTIFIC? Can we evaluate the PCM approach? Yes, based on patients satisfaction with regard to personal outcomes and expectations: RCTs are possible Is it possible to use PSOI to evaluate drug effects? Yes, to show that the effect is not only determined through statistical analysis (Can it?) Can drug development benefit from PCM approach? Yes, because the effect in few will be diluted in the population Market for few is scary for both pharma and public health agency Can PCM informs public health impact of the drug? Yes, accumulation of data regarding drug utility at individual level gives information on the added value the drug at societal level Can PCM enable comparing different strategies to treat a condition? Yes, by comparing the success rate at individual level and aggregating the number of success by group.
21 Conclusion 1 Traditional Chinese Medicine has a tradition behind patient centred approaches However, TCM lacks systematic evaluation WFCMS Although conducting RCTs of TCM should continue There is also the possibility to conduct Patient Centred Medicine, based on Patient Oriented Research To identify treatment utility at individual level In a systematic, rigorous and formal way To justify the Public Health utility of TCM With the PCM design Western and Traditional Chinese Medicines can joined their effort to support patients
22 PCM: Future Direction Conducting Patient Centred Medicine studies For assessing treatment of Chronic Diseases For assessing treatment is situation of Rare Diseases Validity & Reliability Consolidating tools and technology around PCM BCCH N-of-1 platform Goal Attainment Scaling tools (to assess PSOI, for scaling) WFCMS Developing new IT support for patient centred medicine Web applications Automatizing the GAS algorithms Automatizing the symptom capture Automatizing the utility assessment
23
24 CHARACTERISTICS Ev. B MEDICINE PC B MEDICINE MODEL Evidence-based Patient Centred DOMAIN Policy, GCP Patient s opinion EVIDENCE DECISION BASED ON Obtained at population level Published data Obtained at individual level Individual s decision QUALITY ASSESSMENT Audit Satisfaction IMPLEMENTATION QI and KT for CPG implementation Clinical practice approach TOOLS QI techniques Goal Attainment Scaling
Integrating the Best of Traditional Chinese Medicine with Conventional Healthcare
Integrating the Best of Traditional Chinese Medicine with Conventional Healthcare Justin Wu Director, Hong Kong Institute of Integrative Medicine Associate Dean (Clinical), Faculty of Medicine The Chinese
More informationEXPLAINING 4 Imbalances and 5 Organs
4 IMBALANCES AND 5 ORGANS A New System for Diagnosis and Treatment EXPLAINING 4 Imbalances and 5 Organs Jeremy Ross www.jeremyross.com DIFFERENTIAL QUESTIONS A New System for Diagnosis 90 Organ syndromes
More informationIntro to Nutrition and Food Therapy in Traditional Chinese Medicine
Intro to Nutrition and Food Therapy in Traditional Chinese Medicine GOAL OF THE COURSE Introduce TCM theories, especially focused on food and digestion Discuss modern dietary issues Explore therapeutic
More informationThe Foundations of Oriental Medicine Expanded Content Outline
The Foundations of Oriental Medicine Expanded Content Outline (Effective as of February 1, 2014) Note to Candidate: This document serves as a guide to assist in examination preparation for candidates who
More informationDementia of the Alzheimer Type: the Drug Treatment Debate
Dementia of the Alzheimer Type: the Drug Treatment Debate I have no financial conflict of interest. Many years ago I was given a trip to San Fran and taught to use a slide set from the drug company. I
More informationThe Art & Science of Acupuncture for Physicians
The Art & Science of Acupuncture for Physicians Watch Mandatory Recorded Modules Online Must Complete Associated Modules & Sessions Before Attending Clinical Weekends Location: Modules & sessions watched
More informationFang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan
Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan Outline Herbal Medicines in the U.S. Herbal Medicines in EU Herbal Medicines in Australia Herbal Medicines in Asia & Taiwan Regulatory Strategy
More informationFoundations of Traditional Chinese Medicine
SUBJECT OUTLINE Subject Name: Foundations of Traditional Chinese Subject Code: CMPR113 SECTION 1 - GENERAL INFORMATION Award/s: Total Course Credit Points: Level: Bachelor of Health Science (Acupuncture)
More informationThe Foundations of Oriental Medicine Content Outline Effective January 1, 2020
The Foundations of Oriental Medicine Content Outline Effective January 1, 2020 Note to Candidate: This document serves as a guide to assist in examination preparation for candidates who have met NCCAOM
More informationMEDICAL SURGICAL NURSING II VNRS B85 ASSESSING CLIENTS WITH PERIPHERAL VASCULAR AND LYMPHATIC DISORDERS
MEDICAL SURGICAL NURSING II VNRS B85 ASSESSING CLIENTS WITH PERIPHERAL VASCULAR AND INTRODUCTION: Clients with disorders of the peripheral vascular and lymphatic system experience a wide variety of circulatory
More informationThe Foundations of Oriental Medicine Abbreviated Content Outline
The Foundations of Oriental Medicine Abbreviated Content Outline (Effective as of February 1, 2014) Note to Candidate: This document serves as a guide to assist in examination preparation for candidates
More informationHeterozygous Fabry Disease Females Are Not Just Carriers, But Suffer From
Heterozygous Fabry Disease Females Are Not Just Carriers, But Suffer From Significant Burden of Disease And Impaired Quality of Life Raymond Wang, M.D. Children s Hospital of Orange County Division of
More informationTCM Ideology and Methodology
Journal of Traditional Chinese Medicine, June 2011; 31(2): 147-151 147 TCM Ideology and Methodology The TCM Pattern of the Six-Zang and Six-Fu Organs Can Be Simplified into the Pattern of Five-Zang and
More informationOur ongoing interest in spirit
Soothing the Troubled Spirit with Blue Poppy Originals Formulas with Honora Lee Wolfe Our ongoing interest in spirit Western practitioners of Chinese medicine have always had more interest in diseases
More informationAcademy of Classical Oriental Sciences
Academy of Classical Oriental Sciences ACUPUNCTURIST PROGRAM (3 years) Term 1 101. Fundamentals of TCM (lecture) Introduction to fundamental theories including: YinYang; Qi; five phases; six essential
More informationSR/HTAs take unacceptably long time but information is needed now!
HTA Rapid Reviews What are they? How to do it? How can they improve decision making? Agustín Ciapponi Cochrane Argentina Director, Instituto de Efectividad Clínica y Sanitaria (IECS), Argentina SR/HTAs
More informationMedication Policy Manual. Topic: Fabrazyme, agalsidase beta Date of Origin: February 17, 2015
Medication Policy Manual Policy No: dru391 Topic: Fabrazyme, agalsidase beta Date of Origin: February 17, 2015 Committee Approval Date: March 13, 2015 Next Review Date: March 2016 Effective Date: July
More informationEfficacy and Acceptability of Pharmacological Treatments for Post- Stroke Depression: A Bayesian Network Meta-Analysis
Efficacy and Acceptability of Pharmacological Treatments for Post- Stroke Depression: A Bayesian Network Meta-Analysis Presenter: Miss Deng Tutor: Prof. Liu Ming Department of Neurology West China Hospital
More informationInt. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences
Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,
More informationApproved: CAE Hours General 12 General 12. Requested: CAE Hours
Title Distance Learning Requested: Type Mastering Success: Apprenticeship for the Doctor of the Future, Part II Requested: CAE Hours Approved: Type Approved: CAE Hours General 12 General 12 Action, Additional
More informationJNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
More informationA Primer on Health Economics & Integrating Findings from Clinical Trials into Health Technology Assessments and Decision Making
Presenter: Chris Cameron CANNeCTIN November 8, 2013 A Primer on Health Economics & Integrating Findings from Clinical Trials into Health Technology Assessments and Decision Making Acknowledgements Vanier
More informationOutline. Background. Methods and Paths for evaluation. Case Reports
Outline Background Methods and Paths for evaluation Case Reports China Academy of Chinese Medical Science Institute of Basic Research in Clinical Medicine Clinical Evaluation Center The clinical evaluation
More informationCourse: Foundations of Chinese Medicine II Date: June 6, 2007 Class #: 7. Etiology
Course: Foundations of Chinese Medicine II Date: June 6, 2007 Class #: 7 General Introduction Etiology Wikipedia defines the word etiology as the study of causation in general. But more importantly for
More informationThe Chinese University of Hong Kong The Nethersole School of Nursing. CADENZA Training Programme
The Chinese University of Hong Kong The Nethersole School of Nursing CTP003 Chronic Disease Management and End-of-life Care Web-based Course for Professional Social and Health Care Workers Copyright 2012
More informationCourse: Formulas 1 Date: September 30, 2009 Class #: 2 Prof: Dr. Ma
Course: Formulas 1 Date: September 30, 2009 Class #: 2 Prof: Dr. Ma WEEK TWO: Class 2 Goals: Students will learn traditional treatment methods - sweating, vomiting, draining downward, harmonizing, warming,
More informationAcupuncture and Herbs Eliminate Meniere s Disease
Acupuncture and Herbs Eliminate Meniere s Disease Published by HealthCMi on June 2018 Acupuncture has been proven clinically effective for the treatment of Meniere s disease, a disorder characterized by
More informationPatient-Centered Cancer Treatment Planning: Improving the Quality of Oncology Care
Patient-Centered Cancer Treatment Planning: Improving the Quality of Oncology Care Carolyn M. Clancy, MD Director Agency for Healthcare Research and Quality IOM National Cancer Policy Forum and the National
More informationConsolidated Comprehensive Research Plan: Pharmacologic Treatment of Attention Deficit Hyperactivity Disorder in Adults
FINAL Consolidated Comprehensive Research Plan: Pharmacologic Treatment of Attention Deficit Hyperactivity Disorder in Adults April 29 th, 2015 30 Bond Street, Toronto ON, M5B 1W8 www.odprn.ca info@odprn.ca
More informationResearch Article Study on TCM Syndrome Differentiation of Primary Liver Cancer Based on the Analysis of Latent Structural Model
Evidence-Based Complementary and Alternative Medicine Volume 215, Article ID 761565, 9 pages http://dx.doi.org/1.1155/215/761565 Research Article Study on TCM Syndrome Differentiation of Primary Liver
More informationPatient Reported Outcomes
Date Patient Reported Outcomes Presented by: Ari Gnanasakthy RTI Health Solutions 9 th Feb 2015 RTI Health Solutions Research Triangle Park, NC, USA Ann Arbor, MI, USA Barcelona, Spain Ljungskile, Sweden
More informationHealth and Quality of Life Outcomes BioMed Central
Health and Quality of Life Outcomes BioMed Central Research Development and validation of the Chinese Quality of Life Instrument Kwok-fai Leung 1, Feng-bin Liu* 2, Li Zhao 3, Ji-qian Fang 4, Kelvin Chan
More informationEffective Health Care Program
Comparative Effectiveness Review Number 37 Effective Health Care Program Chronic Kidney Disease Stages 1 3: Screening, Monitoring, and Treatment Executive Summary Objectives This systematic review evaluates
More information1. In Oriental medicine, what two organs are related to the earth element? 2. In Oriental medicine what two organs are related to the wood element?
THIS SECTION IS ON ORIENTAL MODALITIES. SOME EXAMS HAVE SEVERAL QUESTIONS ON ORIENTAL MODALITIES HOWEVER THE MBLEx DOES NOT FOCUS ON THE SPECIFICS OF ORIENTAL MODALITIES 1. In Oriental medicine, what two
More informationAccess to newly licensed medicines. Scottish Medicines Consortium
Access to newly licensed medicines Scottish Medicines Consortium Modifiers The Committee has previously been provided with information about why the SMC uses modifiers in its appraisal process and also
More informationINTERNAL CANON OF THE YELLOW EMPEROR TCM DIAGNOSIS METHODS. Stanley Liang Ph.D., R.TCMP, R.Ac
INTERNAL CANON OF THE YELLOW EMPEROR TCM DIAGNOSIS METHODS Stanley Liang Ph.D., R.TCMP, R.Ac Text reading S17 Discussion on the Essentials of Pulse S18 Discussion on the Pulse Conditions of Healthy People
More informationSeptember 30, Eric BASTINGS, MD. Acting Director Division of Neurology Products (DNP) Center for Drug Evaluation and Research (CDER)
ISCTM Autumn Conference Options and methods to improve cognitive assessment in clinical trials of AD and its precursors September 30, 2013 Eric BASTINGS, MD Acting Director Division of Neurology Products
More informationGLUCOSE TESTING-BLOOD
648.83 ABNORMAL GLUCOSE TOLERANCE COMPLICATING PREGNANCY, CHILDBIRTH OR THE PUERPERIUM, ANTEPARTUM CONDITION OR 648.84 ABNORMAL GLUCOSE TOLERANCE COMPLICATING PREGNANCY, CHILDBIRTH OR THE PUERPERIUM, POSTPARTUM
More informationManufacturer Comments Clinical Evidence Review Report and Supplemental Update and Pharmacoeconomic Review Report
Manufacturer Comments Clinical Evidence Review Report and Supplemental Update and Pharmacoeconomic Review Report Drug Product Generic name (Brand name) Manufacturer (Distributor if applicable) Alzheimer
More informationTECH 646 Analysis of Research in Industry and Technology
TECH 646 Analysis of Research in Industry and Technology Ch 6. Research Design: An Overview Based on the text book and supplemental materials from the text book: Cooper, D.R., & Schindler, P.S., Business
More informationNew and Improved 8 Principles in Clinical Practice: 3 Most Important Dichotomies. Bruce Ferguson, DVM, MS Holistic Veterinary Care
New and Improved 8 Principles in Clinical Practice: 3 Most Important Dichotomies Bruce Ferguson, DVM, MS Holistic Veterinary Care www.naturalvet.org Introduction It is said that Chinese Medicine (TCVM)
More informationDrug repurposing for quicker, cheaper, less risky R&D in rare diseases
Drug repurposing for quicker, cheaper, less risky R&D in rare diseases = Drug repositioning = Drug reprofiling = Therapeutic switching A technology company with a social mission, focused on drug repurposing
More informationDrugs for Overactive Bladder (OAB)
ril 2014 Drugs for Overactive Bladder (OAB) FINAL CONSOLIDATED COMPREHENSIVE RESEARCH PLAN July 2015 FINAL COMPREHENSIVE RESEARCH PLAN 2 A. Introduction The objective of the drug class review on drugs
More informationMission, Values and Vision. 1. To promote a long, joyous, healthier life and to provide affordable, compassionate holistic medical care for islanders.
Washington Institute of Natural Sciences School of Acupuncture School of Herbal Medicine Community Clinic Center for Integrative Medicine Bringing a Natural Science College to Friday Harbor, San Juan Island
More informationFive Virtues Center for Acupuncture
Five Virtues Center for Acupuncture Case Study: Headaches and Amenorrhea By Ross Rosen and Jennifer Sobonski History: Patient is a 15- year- old girl who was referred with headaches and amenorrhea. Her
More informationTRADITIONAL CHINESE MEDICINE Alliance for Global Education Public Health Policy and Practice Program in Shanghai
TRADITIONAL CHINESE MEDICINE Alliance for Global Education Public Health Policy and Practice Program in Shanghai Suggested US semester credit hours: 3 credits IFSA-Butler/Alliance course code: HLSC 300
More informationFall 2018 Course Planner
Fall 2018 Course Planner Career Development or Personal Interest Days, Evenings & Weekends Full-Time or Part-Time Study Fall Semester Starts September 24 th, 2018 Register by August 31 st and Save! 380
More informationPHASE 2 C LINICAL TRIAL REPORT OF SUNRECOME (formerly CGLE) FOR ADJUVANT TUMOR TREATMENT. (This report has been translated from Mandarin Chinese.
PHASE 2 C LINICAL TRIAL REPORT OF SUNRECOME (formerly CGLE) FOR ADJUVANT TUMOR TREATMENT (This report has been translated from Mandarin Chinese.) Sponsored by: Traditional Chinese Medicine Academy, Xi
More informationDiscovering Breakthrough Treatments for Human Disease. Discovering Breakthrough Treatments for Human Disease
Patient Reported Outcomes in Oncology Trials Pablo Lapuerta, MD Executive Vice President and Chief Medical Officer Discovering Breakthrough Treatments for Human Disease Discovering Breakthrough Treatments
More informationDistribution Law and Dynamic Evolution of Zheng in TCM
SMGr up Distribution Law and Dynamic Evolution of Zheng in TCM Jie Wang 1, Jia-liang Gao 1, Hong-zheng Li 1,2, Hao-qiang He 1,2, Chao Liu 1,2, Jun Li 1, Yan-wei Xing 1, Kui-wu Yao 1 and Guang Chen 1,2
More informationFabry Disease and the Kidneys
Department of Human Genetics Division of Medical Genetics Lysosomal Storage Disease Center www.genetics.emory.edu Fabry Disease and the Kidneys What is Fabry Disease? Fabry disease (FD) is an X-linked
More informationLayered Approaches to Studying Drug Responses
Layered Approaches to Studying Drug Responses Brian B Hoffman, MD Chief of Medicine VA Boston Health Care System Professor of Medicine Harvard Medical School Conflict of Interest: US Federal Grant Funding
More informationTitle of Study: Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil
SYNOPSIS Name of Sponsor/Company Name of Finished Product REMINYL Name of Active Ingredient(s) Galantamine hydrobromide Issue Date: 18 October 2013 Protocol No.: Title of Study: Evaluation of Efficacy
More informationFOUNDATIONS OF TRADITIONAL CHINESE MEDICINE SUBJECT STUDY GUIDE Semester 1, 2018
FOUNDATIONS OF TRADITIONAL CHINESE MEDICINE SUBJECT STUDY GUIDE Semester 1, 2018 Last updated on 29-Jan-18 Page 1 of 18 FOUNDATIONS OF TRADITIONAL CHINESE MEDICINE SUBJECT STUDY GUIDE As students in the
More informationSimple Steps: The Chinese Way to Better Health
Simple Steps: The Chinese Way to Better Health Lynn Jaffee, L.Ac. Copyright 2008 Lynn Jaffee. All rights reserved ISBN: 1-4392-1836-6 ISBN-13: 9781439218365 Table of Contents Introduction v Chapter 1 What
More informationCourse: Diagnostics II Date: Class #: 2
Course: Diagnostics II Date: 10-03-07 Class #: 2 Eight principles cont d Know: what is true/what is false (true cold/false heat for example) Know yin deficiency symptoms Know exterior/interior dx. Note:
More informationIMPROVED OUTCOMES WHEN COMBINING TCM WITH WESTERN INTERVENTIONS FOR CANCER
IMPROVED OUTCOMES WHEN COMBINING TCM WITH WESTERN INTERVENTIONS FOR CANCER by Jake Paul Fratkin, OMD, Lac Acupuncture Today, September, 2005 Patients undergoing treatment for cancer is becoming more commonplace
More informationHow Acupuncture and Oriental Medicine Can Help You Build a Resilient Body ALYSSA JOHNSON, L. AC, MA. OM
How Acupuncture and Oriental Medicine Can Help You Build a Resilient Body ALYSSA JOHNSON, L. AC, MA. OM What is Oriental Medicine? or Traditional Chinese Medicine Oriental Medicine (OM) =Traditional Chinese
More informationA Channel Based Approach
A Channel Based Approach Meridian Circuits A meridian circuit is composed of meridians that are interconnected according to either their Chinese names, the internal-external relationships, or the horary
More informationThe Body of Chinese Medicine and Contemporary Practice
The Body of Chinese Medicine and Contemporary Practice Mary Garvey Thesis for the degree of Doctor of Philosophy in International Studies Submitted 2011 Certificate I certify that the work in this thesis
More informationChinese Medicine in the omics era
Chinese Medicine in the omics era Prof. Giovanna Franconi Systems Medicine Department Tor Vergata University, Rome, Italy giovanna.franconi@uniroma2.it Western Medicine crisis: Exponential increase of
More informationPatient engagement & research ethics: tensions and opportunities
Patient engagement & research ethics: tensions and opportunities Julie M. Robillard, PhD Assistant Professor of Neurology University of British Columbia Scientist, Patient Experience BC Children s and
More informationImportant Issues in Patient Reported Outcomes (PRO) Research
Important Issues in Patient Reported Outcomes (PRO) Research Feb. 16, 2001 Organized by The Harmonization Coordination Committee Representing European Regulatory Issues on Quality-of of-life Assessment
More informationGalafold (migalastat) or Fabrazyme (agalsidase beta) Prior Authorization Criteria:
Request for Prior Authorization for Fabry Disease Medications Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 All requests for Galafold (migalastat) or Fabrazyme (agalsidase
More informationTRADITIONAL CHINESE MEDICINE (TCM)
FactSHEET TRADITIONAL CHINESE MEDICINE (TCM) A brief history of traditional Chinese medicine The term traditional Chinese medicine (TCM) is used to describe the system of medicine that has developed in
More informationThe Cost Effectiveness of Omacor post-myocardial infarction in the Irish Healthcare Setting
The Cost Effectiveness of Omacor post-myocardial infarction in the Irish Healthcare Setting April 2013 1. Omacor is a concentrated preparation of omega-3-acid ethyl esters that contains 46% eicosapentaenoic
More informationREGULATION AND HTA OF MEDICAL DEVICES IN EU: WHAT CAN WE LEARN?
REGULATION AND HTA OF MEDICAL DEVICES IN EU: WHAT CAN WE LEARN? Rosanna Tarricone, PhD Associate Dean, Government Health and Non Profit Division Issue Panel Opportunities and challenges in international
More informationChapter 15 Substances that Subdue Liver Yang and Extinguish Liver Wind
Course: Chinese Herbology 3 Date: June 16, 2009 Class #: 9 Chapter 15: Sub LV Yang and Ext LV Wind Chapter 15 Substances that Subdue Liver Yang and Extinguish Liver Wind Already covered many herbs that
More informationJessie S. M. CHAN MPH, PhD candidate Centre on Behavioral Health Department of Social Work and Social Administration The University of Hong Kong
Effects of Qigong exercise and its doseresponse relationship in reducing fatigue for patients with Chronic Fatigue Syndrome: A randomized waitlist-controlled trial Jessie S. M. CHAN MPH, PhD candidate
More informationTable 1. Traditional Chinese Medicine Syndrome Differentiation Diagnostic Criteria for Apoplexy Scale
Table. Traditional Chinese Medicine Syndrome Differentiation Diagnostic Criteria for Apoplexy Scale TCM Item Acute ischemic stroke related symptoms and signs Score Wind Onset Peaked 8 hours Peaked hours
More informationDr David Spriggs. General Physician and Geriatrician Auckland City Hospital Auckland. 16:30-16:55 The Sceptics View of Evidence Based Medicine.
Dr David Spriggs General Physician and Geriatrician Auckland City Hospital Auckland 16:30-16:55 The Sceptics View of Evidence Based Medicine. David Spriggs General Physician/Geriatrician Auckland District
More informationPMDA Considerations for Outcome Assessments
PMDA Considerations for Outcome Assessments Keiju Motohashi Office of New Drug II Pharmaceuticals and Medical Devices Agency/ The University of Tokyo Hospital Disclaimer The views and opinions expressed
More informationWhy Should Health Schools Embrace Integrative Health? Stephen M. Sagar MD
Why Should Health Schools Embrace Integrative Health? Stephen M. Sagar MD Professor of Oncology, McMaster University, Canada No conflicting interests What is Integrative Health? Seamless combination of
More informationThe use of pathology surrogate markers in Fabry Disease. Beth L. Thurberg MD PhD Vice President of Pathology Genzyme
Disclaimer: Presentation slides from the Rare Disease Workshop Series are posted by the EveryLife Foundation for Rare Diseases for educational purposes only. They are for use by drug development professionals
More informationAnterior Segment Disease and the Systemic Link Mile Brujic, OD, FAAO
Anterior Segment Disease and the Systemic Link Mile Brujic, OD, FAAO brujic@prodigy.net Summary As optometry s role in health care increases, so does our responsibility to appropriately diagnose and appropriately
More informationUpper Jiao problem Pallor of face Qi/Yang/Blood Xu or Cold Can be excess, or Blood Deficiency
Course: Diagnostics II Date: Dec 8, 2007 Combination Symptoms Combination Syndrome Symptom Caused by Qi Deficiency of Heart and Lung Palpitation Indicative of heart problem Cough with difficult inhalation,
More informationDr. of TCM Program (DTCM)
Dr. of TCM Program (DTCM) Year 1 Credits AU History of TCM 2 TF TCM Foundation (1) 6 WM Anatomy (1) 3 WM Surface Anatomy 1 WM Physiology (1) 4 AU Chinese Medical Terminology (1) 2 AU Medical Qi Gong &Tai
More informationOriental Medical Physiology. Shaoyin (Heart and Kidney) Physiology
Oriental Medical Physiology Shaoyin (Heart and Kidney) Physiology Six Levels of Physiology In Chinese Medicine Taiyang (UB/SI) Opens outward (to outside) Shaoyang (GB/SJ) Pivot Yangming (LI/ST) Closes
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response
More informationPossible Cardiovascular System Abnormality. Opening and closing of a coronary artery Inflammation of the outside lining of the heart
JAMES L. MARCUM Symptom Chest pain (2) Shortness of breath (dyspnea) Possible Cardiovascular System Abnormality Complete blockage of a coronary artery leading to the heart Partial blockage Opening and
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives
Blood Pressure Control role of specific antihypertensives Date written: May 2005 Final submission: October 2005 Author: Adrian Gillian GUIDELINES a. Regimens that include angiotensin-converting enzyme
More informationTraditional Chinese Medicine 101: Know more about your body and yourself
Traditional Chinese Medicine 101: Know more about your body and yourself Overview This course is an introduction to Traditional Chinese Medicine (TCM), including its theories, diagnostic methods, and its
More informationPATIENT REPORTED OUTCOMES
Introduction to Clinical Research: A Two-week Intensive Course PATIENT REPORTED OUTCOMES Albert W. Wu, MD, MPH Overview 1. Importance of patient perspective 2. Definitions 3. Key concepts to measure as
More informationResearch Article Clinical and Epidemiological Investigation of TCM Syndromes of Patients with Coronary Heart Disease in China
Evidence-Based Complementary and Alternative Medicine Volume 2012, Article ID 714517, 5 pages doi:10.1155/2012/714517 Research Article Clinical and Epidemiological Investigation of TCM Syndromes of Patients
More informationThe contractor establishes and maintains a register of patients with AF
Atrial Fibrillation The contractor establishes and maintains a register of patients with AF G5731 Those patients with AF in whom there is a record of CHADS2 score of 1, the % of patients who are currently
More informationSUMMARY REPORT OF ACUPUNCTURE SESSION
SUMMARY REPORT OF ACUPUNCTURE SESSION 1 Presenter: Jaung-Geng Lin 2 Introduction to acupuncture session In this session, we had 26 posters and 12 posters were selected for presentation and discussion.
More informationAllergan Not Applicable AGN A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose, Parallel
Peripheral Neuropathy Design, Dose Ranging Study of the Safety and Efficacy of AGN 203818 in Patients with Painful Diabetic 203818-004. A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Multiple
More informationRecommendations on Screening for Cognitive Impairment in Older Adults 2015
Recommendations on Screening for Cognitive Impairment in Older Adults 2015 Canadian Task Force on Preventive Health Care (CTFPHC) Putting Prevention into Practice Canadian Task Force on Preventive Health
More informationThe place for treatments of associated neuropsychiatric and other symptoms
The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public
More informationHierarchical Latent Class Models and Statistical Foundation for Traditional Chinese Medicine
Hierarchical Latent Class Models and Statistical Foundation for Traditional Chinese Medicine Nevin L. Zhang 1, Shihong Yuan 2, Tao Chen 1, and Yi Wang 1 1 Hong Kong University of Science and Technology,
More informationEvidence-based Laboratory Medicine: Finding and Assessing the Evidence
Find Assess Decide Evidence-based Laboratory Medicine: Finding and Assessing the Evidence Pieter Vermeersch, M.D. Ph.D. Laboratory Medicine, UZ Leuven November 18th 2008 Introduction Archie Cochrane (1908-1988)
More informationNATIONAL SYNERGISTIC CORE RESOURCES. Kidney REsearch Scientist Core Education and National Training program (KRESCENT)
Strategy for Patient-Oriented Research Putting Patients First VISION Can-SOLVE CKD Network Vision: By 2020, every Canadian with, or at high risk for, chronic kidney (CKD) will receive the best recommended
More informationThe University of Jordan. Program: PharmD Academic Year/ Semester: Complementary And Alternative Medicine ( ) Level 4
The University of Jordan Faculty: Pharmacy Department: Pharmaceutical Sciences Program: PharmD Academic Year/ Semester: 2014-2015 Complementary And Alternative Medicine (1201414) Credit hours 3 Level 4
More informationDISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.
JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I
More information